A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Conditions
Lymphoma, Non-Hodgkin · Lymphoma, Follicular · Lymphoma, Large B-Cell, Diffuse
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Colorado Blood Cancer Institute ( Site 7000), Denver, Colorado, United States
SCRI Oncology Partners ( Site 0100), Nashville, Tennessee, United States
Instituto Alexander Fleming ( Site 1404), Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Sanatorio Nuestra Senora del Rosario ( Site 1403), Rosario, Santa Fe Province, Argentina
Beijing Cancer hospital ( Site 1701), Beijing, Beijing Municipality, China
Shaare Zedek Medical Center ( Site 0603), Jerusalem, Israel
Haddasah Medical Center ( Site 0600), Jerusalem, Israel
Sheba Medical Center ( Site 0601), Ramat Gan, Israel
Sourasky Medical Center. ( Site 0604), Tel Aviv, Israel
INOC - Istituto Nazionale Oncologico Candiolo ( Site 0701), Candiolo, Piedmont, Italy
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Chłonnego ( Site 0900), Warsaw, Masovian Voivodeship, Poland
Pratia Onkologia Katowice ( Site 0902), Katowice, Silesian Voivodeship, Poland
Institut Català d'Oncologia (ICO) - Badalona ( Site 1103), Badalona, Barcelona, Spain
Hospital Virgen de la Victoria ( Site 1104), Málaga, Malaga, Spain
Hospital Universitari Vall de Hebron ( Site 1102), Barcelona, Spain
Hospital Universitario Gregorio Maranon ( Site 1101), Madrid, Spain
Hospital Universitario 12 de Octubre ( Site 1105), Madrid, Spain
Hacettepe Universitesi Tip Fakultesi Hastanesi ( Site 1000), Ankara, Turkey (Türkiye)
Koç Üniversitesi Hastanesi ( Site 1001), Istanbul, Turkey (Türkiye)
Derriford Hospital ( Site 1304), Plymouth, Devon, United Kingdom
The Christie NHS Foundation Trust ( Site 1300), Manchester, United Kingdom
Study leads
Medical Director
Study Director
Merck Sharp & Dohme LLC